Literature DB >> 673014

The neuronal and extraneuronal uptake and metabolism of 3H-(-)-noradrenaline in the perfused rat heart.

E R Fiebig, U Trendelenburg.   

Abstract

1. Hearts were obtained from reserpine-pretreated rats and perfused with 0.95 micron 3H(-)-noradrenaline. The rate of removal of 3H-noradrenaline from the perfusion fluid was measured (from the arterio-venous difference) as well as the rate at which the 3H-metabolites appeared in the venous effluent. 2. When either 30micron corticosterone was added under steady-state conditions during perfusion with 3H-noradrenaline (to inhibit neuronal and extraneuronal uptake, respectively), each inhibitor reduced the removal of noradrenaline by about 50%; in the presence of both inhibitors removal was abolished. 3. Dihydroxymandelic acid (DOMA) was of neuronal, normetanephrine (NMN) of extraneuronal origin; dihydroxyphenylglycol (DOPEG) and the OMDA fraction (containing methoxyhydroxyphenylglycol-MOPEG-and methoxyhydroxymandelic acid-VMA) were formed both neuronally and extra-neuronally. 4. The extraneuronal metabolism of 3H-noradrenaline was in quick equilibrium with the 3H-noradrenaline in the perfusion fluid; most of the total formation of DOPEG, MOPEG and NMN was recovered from the venous effluent. 5. Extraneuronally formed DOPEG, MOPEG and NMN distributed in the tissue with half times corresponding to their half time for efflux. 6. Inhibition of monoamine oxidase (MAO) by pargyline increased the extraneuronal formation of NMN; MAO and catechol-O-methyl transferase (COMT) appear to be contained in the same extraneuronal compartment. 7. The extraneuronal accumulation of 3H-noradrenaline required 30 min or more to reach a steady state; inhibition of one or both enzymes slowed this process. Inhibition of MAO increased the extra-neuronal accumulation of 3H-noradrenaline; inhibition of COMT failed to do so, since the enzyme inhibitor (U-0521) was a weak inhibitor of extra-neuronal uptake. 8. The rate constants for the efflux of the metabolites of noradrenaline decreased in the order of MOPEG greater than DOPEG greater than NMN greater than DOMA greater than VMA.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 673014     DOI: 10.1007/BF00496182

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  [THE EFFECT OF DRUGS ON THE ELIMINATION OF NORADRENALIN FROM PERFUSION FLUID AND NORADRENALIN UPTAKE IN THE ISOLATED HEART].

Authors:  R LINDMAR; E MUSCHOLL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-07-28

2.  The effect of inhibitors of extraneuronal uptake on the distribution of 3H-(+/-)noradrenaline in nerve-free rabbit aortic strips.

Authors:  E Eckert; M Henseling; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

3.  Selective metabolic pathways for noradrena-line in the peripheral and in the central nervous system.

Authors:  S Z Langer
Journal:  Med Biol       Date:  1974-12

4.  The O-methylation of extraneuronally stored isoprenaline in the perfused heart.

Authors:  W Uhlig; H Bönisch; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

6.  Stability of cardiac monoamine oxidase activity after chemical sympathectomy with 6-hydroxydopamine.

Authors:  M C Lowe; A Horita
Journal:  Nature       Date:  1970-10-10       Impact factor: 49.962

7.  The metabolism of tritiated dopamine in regions of the rat brain in vivo. I. The separation of catecholamines and their metabolites.

Authors:  K M Taylor; R Laverty
Journal:  J Neurochem       Date:  1969-09       Impact factor: 5.372

8.  The kinetic constants for the extraneuronal uptake and metabolism of 3H-(-)-noradrenaline in the perfused rat heart.

Authors:  E R Fiebig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

9.  The relationships between alpha receptor block, inhibition of norepinephrine uptake and the release and metabolism of 3H-norepinephrine.

Authors:  L Cubeddu; S Z Langer; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1974-02       Impact factor: 4.030

10.  The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart.

Authors:  S L Lightman; L L Iversen
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

View more
  34 in total

1.  The handling of five amines by the extraneuronal deaminating system of the rat heart.

Authors:  M Grohmann; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

2.  The neuronal and extraneuronal distribution of 3H(-)-noradrenaline in the perfused rat heart.

Authors:  R Mekanontchai; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

3.  Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat.

Authors:  G Eisenhofer; R McCarty; K Pacak; H Russ; E Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

4.  The outward transport of catecholamines mediated by uptake2 of the rat heart.

Authors:  U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

5.  The effect of partial inhibition of monoamine oxidase on the steady-state rate of deamination of 3H-catecholamines in two metabolizing systems.

Authors:  L Cassis; J Ludwig; M Grohmann; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

6.  3H-WB 4101 binding in the rat vas deferens. Effects of chronic treatments with desipramine and prazosin.

Authors:  H W Wetzel; M S Briley; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

7.  Intra- and extraneuronal metabolism of 5-hydroxytryptamine in the isolated saphenous vein of the dog.

Authors:  M Q Paiva; M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

8.  Changes in the incidence and duration of ventricular fibrillation in dependence on the extraneuronal accumulation of isoprenaline in the perfused rat heart.

Authors:  K Sono; K Kurahashi; M Fujiwara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

9.  Selective inhibition by amezinium of intraneuronal monoamine oxidase.

Authors:  A Steppeler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

10.  Lack of differences between the neuronal and extraneuronal handling of 3H-7- and 3H-ring-2,5,6-(-)noradrenaline.

Authors:  M Grohmann; M Henseling
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.